Search for other papers by Asena Gökçay Canpolat in
Google Scholar
PubMed
Search for other papers by Murat Cinel in
Google Scholar
PubMed
Search for other papers by Serpil Dizbay Sak in
Google Scholar
PubMed
Search for other papers by Işılay Taşkaldıran in
Google Scholar
PubMed
Search for other papers by Hakan Korkmaz in
Google Scholar
PubMed
Search for other papers by Özgür Demir in
Google Scholar
PubMed
Search for other papers by Reyhan Ersoy in
Google Scholar
PubMed
Search for other papers by Selçuk Dağdelen in
Google Scholar
PubMed
Search for other papers by Dilek Berker in
Google Scholar
PubMed
Search for other papers by Klara Dalva in
Google Scholar
PubMed
Search for other papers by Adile Begüm Bahçecioğlu Mutlu in
Google Scholar
PubMed
Search for other papers by Murat Faik Erdoğan in
Google Scholar
PubMed
, desmin, p63, CD34, CD31, ICAM-1 antibody (Abcam®, Anti-ICAM-1 antibody [EPR4776]), and TGF-β antibody (Abcam®, Anti-TGF-β antibody [TGF-β17]) stains were performed. Flow Cytometric Study for Plasmablasts The ratio of plasmablast was detected in
Search for other papers by Dulani Kottahachchi in
Google Scholar
PubMed
Department of Medicine, Monash University, Melbourne, VIC, Australia
Search for other papers by Duncan J. Topliss in
Google Scholar
PubMed
and their infiltration into tissue sites may be the cause of this disease state. Reactivation of these CD4+ CTL cells may require antigen presentation by plasmablasts or other activated B cells in tissue sites. Activated CD4+ CTLs presumably mediate